Global Information
회사소개 | 문의 | 비교리스트

세계의 당뇨병 기기 시장 : 유형별, 최종 용도별, 유통별, 지역별 예측(-2026년), COVID-19의 누적 영향

Diabetes Devices Market Research Report by Type, by End Use, by Distribution, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2021년 11월 상품 코드 1035653
페이지 정보 영문 181 Pages
가격
US $ 3,949 ₩ 4,748,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 5,951,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 7,153,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 9,558,000 PDF (Site License) + Excel
US $ 9,949 ₩ 11,963,000 PDF (Enterprise License) + Excel


세계의 당뇨병 기기 시장 : 유형별, 최종 용도별, 유통별, 지역별 예측(-2026년), COVID-19의 누적 영향 Diabetes Devices Market Research Report by Type, by End Use, by Distribution, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
발행일 : 2021년 11월 페이지 정보 : 영문 181 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 당뇨병 기기 시장 규모는 2020년에 259억 1,000만 달러에 이르렀습니다. 2021년에는 277억 5, 000만 달러에 이르고, 그 후 연평균 복합 성장률(CAGR) 7.43%로 성장을 지속하여 2026년까지 398억 5,000만 달러에 달할 것으로 예측됩니다.

세계의 당뇨병 기기(Diabetes Devices) 시장에 대해 조사분석했으며, 시장 개요, 시장 인사이트, 시장 분석, 경쟁 구도, 기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 범위
  • 조사 대상년도
  • 통화와 가격
  • 언어
  • 제한 사항
  • 전제조건
  • 이해관계자

제2장 조사 방법

  • 정의 : 조사 목적
  • 결정 : 조사 디자인
  • 준비 : 조사 기기
  • 수집 : 데이터 소스
  • 분석 : 데이터 해석
  • 책정 : 데이터 검증
  • 공개 : 조사 보고서
  • 반복 : 보고서 업데이트

제3장 개요

제4장 시장 개요

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • COVID-19의 누적 영향

제6장 당뇨병 기기 시장 : 유형별

  • 혈당 모니터링
    • 연속 혈당 모니터링 기기
    • 랜싯/랜싱 기기
    • 자가 혈당 모니터링 기기
    • 테스트 스트립/테스트 페이퍼
  • 인슐린 전달 기기
    • 제트 인젝터
    • 펌프
    • 주사기

제7장 당뇨병 기기 시장 : 최종 용도별

  • 진단센터
  • 홈케어
  • 병원

제8장 당뇨병 기기 시장 : 유통별

  • 당뇨병 클리닉
  • 병원 약국
  • 온라인 약국
  • 소매 약국

제9장 아메리카의 당뇨병 기기 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제10장 아시아태평양의 당뇨병 기기 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 싱가포르
  • 한국
  • 대만
  • 태국

제11장 유럽, 중동 및 아프리카의 당뇨병 기기 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트(UAE)
  • 영국

제12장 경쟁 구도

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석 : 주요 기업별
  • 경쟁 시나리오
    • 인수합병(M&A)
    • 합의/협업/제휴
    • 신제품 발매 및 강화
    • 투자/펀딩
    • 수상/표창/확대

제13장 기업 개요

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • Agamatrix Holdings Llc
  • Arkray, Inc
  • Ascensia Diabetes Care Holdings AG
  • B Braun Melsungen AG
  • Bayer Corporation
  • Becton, Dickinson and Company
  • Bionime Corporation
  • Dexcom Inc.
  • Dr. Morepen
  • F Hoffmann-La Roche AG
  • Insulet Corporation
  • LifeScan, Inc
  • Medtronic PLC
  • Microgene Diagnostic Systems Pvt. Ltd.
  • Novo Nordisk A/s
  • Rossmax International Ltd.
  • Sanofi
  • SD BioSensor Inc.
  • Sinocare, InC.
  • Terumo Corporation
  • Valeritas Holdings Inc.
  • Ypsomed Holding AG

제14장 부록

  • 디스커션 가이드
  • 라이선스와 가격
LSH 21.11.17

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIABETES DEVICES MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL DIABETES DEVICES MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL DIABETES DEVICES MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 4. GLOBAL DIABETES DEVICES MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES DEVICES MARKET SIZE, BY TYPE, 2026
  • FIGURE 6. GLOBAL DIABETES DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING, 2018-2026 (USD BILLION)
  • FIGURE 7. GLOBAL DIABETES DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 8. GLOBAL DIABETES DEVICES MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORING DEVICES, 2018-2026 (USD BILLION)
  • FIGURE 9. GLOBAL DIABETES DEVICES MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 10. GLOBAL DIABETES DEVICES MARKET SIZE, BY LANCETS/ LANCING DEVICES, 2018-2026 (USD BILLION)
  • FIGURE 11. GLOBAL DIABETES DEVICES MARKET SIZE, BY LANCETS/ LANCING DEVICES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 12. GLOBAL DIABETES DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL DIABETES DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL DIABETES DEVICES MARKET SIZE, BY TEST STRIP/ TEST PAPERS, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL DIABETES DEVICES MARKET SIZE, BY TEST STRIP/ TEST PAPERS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL DIABETES DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL DIABETES DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL DIABETES DEVICES MARKET SIZE, BY JET INJECTORS, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL DIABETES DEVICES MARKET SIZE, BY JET INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL DIABETES DEVICES MARKET SIZE, BY PENS, 2018-2026 (USD BILLION)
  • FIGURE 21. GLOBAL DIABETES DEVICES MARKET SIZE, BY PENS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. GLOBAL DIABETES DEVICES MARKET SIZE, BY PUMPS, 2018-2026 (USD BILLION)
  • FIGURE 23. GLOBAL DIABETES DEVICES MARKET SIZE, BY PUMPS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 24. GLOBAL DIABETES DEVICES MARKET SIZE, BY SYRINGES, 2018-2026 (USD BILLION)
  • FIGURE 25. GLOBAL DIABETES DEVICES MARKET SIZE, BY SYRINGES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. GLOBAL DIABETES DEVICES MARKET SIZE, BY END USE, 2020 VS 2026 (%)
  • FIGURE 27. GLOBAL DIABETES DEVICES MARKET SIZE, BY END USE, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES DEVICES MARKET SIZE, BY END USE, 2026
  • FIGURE 29. GLOBAL DIABETES DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2026 (USD BILLION)
  • FIGURE 30. GLOBAL DIABETES DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. GLOBAL DIABETES DEVICES MARKET SIZE, BY HOME CARE, 2018-2026 (USD BILLION)
  • FIGURE 32. GLOBAL DIABETES DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. GLOBAL DIABETES DEVICES MARKET SIZE, BY HOSPITALS, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL DIABETES DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. GLOBAL DIABETES DEVICES MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (%)
  • FIGURE 36. GLOBAL DIABETES DEVICES MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES DEVICES MARKET SIZE, BY DISTRIBUTION, 2026
  • FIGURE 38. GLOBAL DIABETES DEVICES MARKET SIZE, BY DIABETES CLINICS, 2018-2026 (USD BILLION)
  • FIGURE 39. GLOBAL DIABETES DEVICES MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 40. GLOBAL DIABETES DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES , 2018-2026 (USD BILLION)
  • FIGURE 41. GLOBAL DIABETES DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES , BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 42. GLOBAL DIABETES DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 43. GLOBAL DIABETES DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 44. GLOBAL DIABETES DEVICES MARKET SIZE, BY RETAIL PHARMACIES , 2018-2026 (USD BILLION)
  • FIGURE 45. GLOBAL DIABETES DEVICES MARKET SIZE, BY RETAIL PHARMACIES , BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 46. AMERICAS DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 47. ARGENTINA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 48. BRAZIL DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 49. CANADA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 50. MEXICO DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 51. UNITED STATES DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 52. ASIA-PACIFIC DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 53. AUSTRALIA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 54. CHINA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 55. INDIA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 56. INDONESIA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 57. JAPAN DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 58. MALAYSIA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 59. PHILIPPINES DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 60. SINGAPORE DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 61. SOUTH KOREA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 62. TAIWAN DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 63. THAILAND DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 64. EUROPE, MIDDLE EAST & AFRICA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 65. FRANCE DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 66. GERMANY DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 67. ITALY DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 68. NETHERLANDS DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 69. QATAR DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 70. RUSSIA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 71. SAUDI ARABIA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 72. SOUTH AFRICA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 73. SPAIN DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 74. UNITED ARAB EMIRATES DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 75. UNITED KINGDOM DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 76. GLOBAL DIABETES DEVICES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 77. GLOBAL DIABETES DEVICES MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DIABETES DEVICES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL DIABETES DEVICES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL DIABETES DEVICES MARKET SIZE, BY TYPE, 2018-2026 (USD BILLION)
  • TABLE 4. GLOBAL DIABETES DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 5. GLOBAL DIABETES DEVICES MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 6. GLOBAL DIABETES DEVICES MARKET SIZE, BY LANCETS/ LANCING DEVICES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 7. GLOBAL DIABETES DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 8. GLOBAL DIABETES DEVICES MARKET SIZE, BY TEST STRIP/ TEST PAPERS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 9. GLOBAL DIABETES DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 10. GLOBAL DIABETES DEVICES MARKET SIZE, BY JET INJECTORS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 11. GLOBAL DIABETES DEVICES MARKET SIZE, BY PENS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 12. GLOBAL DIABETES DEVICES MARKET SIZE, BY PUMPS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 13. GLOBAL DIABETES DEVICES MARKET SIZE, BY SYRINGES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 14. GLOBAL DIABETES DEVICES MARKET SIZE, BY END USE, 2018-2026 (USD BILLION)
  • TABLE 15. GLOBAL DIABETES DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 16. GLOBAL DIABETES DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 17. GLOBAL DIABETES DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 18. GLOBAL DIABETES DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD BILLION)
  • TABLE 19. GLOBAL DIABETES DEVICES MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 20. GLOBAL DIABETES DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES , BY REGION, 2018-2026 (USD BILLION)
  • TABLE 21. GLOBAL DIABETES DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 22. GLOBAL DIABETES DEVICES MARKET SIZE, BY RETAIL PHARMACIES , BY REGION, 2018-2026 (USD BILLION)
  • TABLE 23. AMERICAS DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 24. ARGENTINA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 25. BRAZIL DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 26. CANADA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 27. MEXICO DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 28. UNITED STATES DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 29. ASIA-PACIFIC DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 30. AUSTRALIA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 31. CHINA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 32. INDIA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 33. INDONESIA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 34. JAPAN DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 35. MALAYSIA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 36. PHILIPPINES DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 37. SINGAPORE DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 38. SOUTH KOREA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 39. TAIWAN DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 40. THAILAND DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 41. EUROPE, MIDDLE EAST & AFRICA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 42. FRANCE DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 43. GERMANY DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 44. ITALY DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 45. NETHERLANDS DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 46. QATAR DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 47. RUSSIA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 48. SAUDI ARABIA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 49. SOUTH AFRICA DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 50. SPAIN DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 51. UNITED ARAB EMIRATES DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 52. UNITED KINGDOM DIABETES DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 53. GLOBAL DIABETES DEVICES MARKET: SCORES
  • TABLE 54. GLOBAL DIABETES DEVICES MARKET: BUSINESS STRATEGY
  • TABLE 55. GLOBAL DIABETES DEVICES MARKET: PRODUCT SATISFACTION
  • TABLE 56. GLOBAL DIABETES DEVICES MARKET: RANKING
  • TABLE 57. GLOBAL DIABETES DEVICES MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 58. GLOBAL DIABETES DEVICES MARKET: MERGER & ACQUISITION
  • TABLE 59. GLOBAL DIABETES DEVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 60. GLOBAL DIABETES DEVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 61. GLOBAL DIABETES DEVICES MARKET: INVESTMENT & FUNDING
  • TABLE 62. GLOBAL DIABETES DEVICES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 63. GLOBAL DIABETES DEVICES MARKET: LICENSE & PRICING

The Global Diabetes Devices Market size was estimated at USD 25.91 billion in 2020 and expected to reach USD 27.75 billion in 2021, at a CAGR 7.43% to reach USD 39.85 billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Diabetes Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Type, the market was studied across Blood Glucose Monitoring and Insulin Delivery Devices. The Blood Glucose Monitoring is further studied across Continuous Blood Glucose Monitoring Devices, Lancets/ Lancing Devices, Self-monitoring Blood Glucose Devices, and Test Strip/ Test Papers. The Insulin Delivery Devices is further studied across Jet Injectors, Pens, Pumps, and Syringes.
  • Based on End Use, the market was studied across Diagnostic Centers, Home Care, and Hospitals.
  • Based on Distribution, the market was studied across Diabetes Clinics, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Diabetes Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Diabetes Devices Market, including Abbott Laboratories, Acon Laboratories, Inc., Agamatrix Holdings Llc, Arkray, Inc, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Bayer Corporation, Becton, Dickinson and Company, Bionime Corporation, Dexcom Inc., Dr. Morepen, F Hoffmann-La Roche AG, Insulet Corporation, LifeScan, Inc, Medtronic PLC, Microgene Diagnostic Systems Pvt. Ltd., Novo Nordisk A/s, Rossmax International Ltd., Sanofi, SD BioSensor Inc., Sinocare, InC., Terumo Corporation, Valeritas Holdings Inc., and Ypsomed Holding AG.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Diabetes Devices Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Diabetes Devices Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Diabetes Devices Market?
  • 4. What is the competitive strategic window for opportunities in the Global Diabetes Devices Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Diabetes Devices Market?
  • 6. What is the market share of the leading vendors in the Global Diabetes Devices Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Diabetes Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing diabetic population and rising awareness of diabetes treatment
      • 5.1.1.2. Rising need for new technologies such as glucose level monitoring
      • 5.1.1.3. Supportive government initiatives for diabetic care
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with advanced medical devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing trend of self-care or home care
      • 5.1.3.2. Increasing mHealth applications
      • 5.1.3.3. Improved functionality with the integration of advanced technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and penetration in underdeveloped areas
  • 5.2. Cumulative Impact of COVID-19

6. Diabetes Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Blood Glucose Monitoring
    • 6.2.1. Continuous Blood Glucose Monitoring Devices
    • 6.2.2. Lancets/ Lancing Devices
    • 6.2.3. Self-monitoring Blood Glucose Devices
    • 6.2.4. Test Strip/ Test Papers
  • 6.3. Insulin Delivery Devices
    • 6.3.1. Jet Injectors
    • 6.3.2. Pens
    • 6.3.3. Pumps
    • 6.3.4. Syringes

7. Diabetes Devices Market, by End Use

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Home Care
  • 7.4. Hospitals

8. Diabetes Devices Market, by Distribution

  • 8.1. Introduction
  • 8.2. Diabetes Clinics
  • 8.3. Hospital Pharmacies
  • 8.4. Online Pharmacies
  • 8.5. Retail Pharmacies

9. Americas Diabetes Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Diabetes Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand

11. Europe, Middle East & Africa Diabetes Devices Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Key Player
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Abbott Laboratories
  • 13.2. Acon Laboratories, Inc.
  • 13.3. Agamatrix Holdings Llc
  • 13.4. Arkray, Inc
  • 13.5. Ascensia Diabetes Care Holdings AG
  • 13.6. B Braun Melsungen AG
  • 13.7. Bayer Corporation
  • 13.8. Becton, Dickinson and Company
  • 13.9. Bionime Corporation
  • 13.10. Dexcom Inc.
  • 13.11. Dr. Morepen
  • 13.12. F Hoffmann-La Roche AG
  • 13.13. Insulet Corporation
  • 13.14. LifeScan, Inc
  • 13.15. Medtronic PLC
  • 13.16. Microgene Diagnostic Systems Pvt. Ltd.
  • 13.17. Novo Nordisk A/s
  • 13.18. Rossmax International Ltd.
  • 13.19. Sanofi
  • 13.20. SD BioSensor Inc.
  • 13.21. Sinocare, InC.
  • 13.22. Terumo Corporation
  • 13.23. Valeritas Holdings Inc.
  • 13.24. Ypsomed Holding AG

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
Back to Top
전화 문의
F A Q